2013
DOI: 10.1016/j.pbb.2013.01.014
|View full text |Cite
|
Sign up to set email alerts
|

Abnormal involuntary movement (AIM) expression following D2 dopamine agonist challenge is determined by the nature of prior dopamine receptor stimulation (priming) in 6-hydroxydopamine lesioned rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 52 publications
1
3
0
Order By: Relevance
“…1A). Similar to previous research (Drake et al, 2013; Dupre et al, 2007; Lindenbach et al, 2013), systemic administration of the D1 receptor agonist SKF81297 and the D2 receptor agonist quinpirole independently induced ALO AIMs (Fig. 5D and F) that were similar to L-dopa-induced AIMs (Fig.…”
Section: Resultssupporting
confidence: 89%
See 1 more Smart Citation
“…1A). Similar to previous research (Drake et al, 2013; Dupre et al, 2007; Lindenbach et al, 2013), systemic administration of the D1 receptor agonist SKF81297 and the D2 receptor agonist quinpirole independently induced ALO AIMs (Fig. 5D and F) that were similar to L-dopa-induced AIMs (Fig.…”
Section: Resultssupporting
confidence: 89%
“…Unfortunately, prolonged L-dopa treatment often leads to the development of abnormal involuntary movements, otherwise known as L-dopa-induced dyskinesia (Jankovic, 2005). Though DA agonists are less likely to induce this side effect (Chondrogiorgi et al, 2014; Stathis et al, 2015), they can also elicit dyskinesia in PD patients (Rascol et al, 2000, 2001) and hemiparkinsonian rats (Drake et al, 2013; Dupre et al, 2007; Lindenbach et al, 2013). While the causes of dyskinesia are not fully understood, several mechanisms appear to be involved in its expression, including increased corticostriatal extracellular glutamate levels, glutamate transporter expression, and glutamate receptor phosphorylation (Calon et al, 2003; Dupre et al, 2011; Robelet et al, 2004; Sgambato-Faure and Cenci, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, the effects of this lesion on grooming asymmetries were not investigated. One study in 6-OHDA-lesioned rats reported intense grooming directed toward the contralateral side to the lesion following treatments with various dopamine agonists but did not describe grooming deficits in untreated animals [ 25 ]. Our study tested whether grooming could be an informative behavioural analysis, about the effects of unilateral 6-OHDA lesion in mice.…”
Section: Discussionmentioning
confidence: 99%
“…This approach differs from that of others that have previously analyzed the involvement of iMSNs in LID ( Alcacer et al., 2017 ; Girasole et al., 2018 ) in which D2R expressing iMSNs were manipulated as a whole. Similarly, using pharmacological approaches a clear participation of D2R/D3R signaling was assessed ( Drake et al., 2013 ; Rascol et al, 2006 ; Sebastianutto et al., 2016 ) but the cell types involved in it were not clarified. Using constitutive knockout of D2Rs in mice it was shown that the total loss of D2R signaling had no effects in L-DOPA-treated dyskinetic mice ( Darmopil et al., 2009 ).…”
Section: Discussionmentioning
confidence: 99%